Product
Allogeneic Derived Cells
1 clinical trial
3 indications
Indication
Heart FailureIndication
Congestive Heart FailureIndication
diastolicClinical trial
Regress-HFpEF: Regression of Fibrosis & Reversal of Diastolic Dysfunction in HFpEF Patients Treated With Allogeneic CDCsStatus: Completed, Estimated PCD: 2023-04-28